Skip to content
Latest News
Luminar ‘Looks Like It’s Heading Under $1’ — Citron Research

Luminar (NASDAQ: LAZR) stock tumbled more than 9% in Friday's session, with Citron Research saying it "looks likes its heading under $1" per share in a tweet.

Sam Boughedda
Poolbeg Pharma Shares Rallied 12.5% on Positive Initial Trial Data

The Poolbeg Pharma PLC (LON: POLB) share price rallied 12.5% after announcing positive results from the initial data analysis from its LPS human challenge trial, which is testing the effectiveness of its POLB 001 drug candida

Simon Mugo
Piper Sandler Remains On Sidelines For Biogen Shares

Biogen (NASDAQ: BIIB) shares jumped Friday after it was announced that the US Food and Drug Administration (FDA) had granted accelerated approval for the company and Eisai Co's Alzheimer's drug, Leqembi.

Sam Boughedda
Which Companies Are Announcing UK Earnings This Week — January 9

This week we can expect updates from more retailers, which we hope will have also experienced a boost over the Christmas period. Names including JD Sports, Sainsbury, Halfords, and Marks & Spencer are expected to provide

AskTraders Team
Why Nanoco Shares Plunged 23% on Samsung Settlement Details

The Nanoco Group PLC (LON: NANO) share price plunged 23.3% after revealing more details about its planned settlement with Samsung to avoid the long and tedious litigation process that could have cost it time and money.

Simon Mugo
Tortilla Mexican Grill Shares Up As FY22 Profit Seen In Line With Expectations

Tortilla Mexican Grill (LON: MEX) shares have edged higher early Monday after it said trading since its last update in early October has been strong, and it sees FY22 revenue and profit in line with market expectations.

Sam Boughedda
DeepVerge Shares Rise As 2022 Revenue Jumps — Slightly Below Expectations

DeepVerge (LON: DVRG) said in a release Monday morning that revenue for 2022 came in below market expectations. The company told investor

Sam Boughedda
Hemogenyx (HEMO) Shares Surged 32.9% on New Antiviral Tech

The Hemogenyx Pharmaceuticals PLC (LON: HEMO) share price surged 32.9% after revealing that it had made significant progress developing its Chimeric Bait Receptor (CBR) platform technology, which can be used to combat multipl

Simon Mugo
Crypto Gains Post US Employment, Polygon MATIC Price Forecast

The broader cryptocurrency market was mostly higher last Friday and over the weekend in the wake of the release of the US Employment report, and also for the week. Polygon MATIC/USD also rallied, which sets up a more bullish

Steve Miley
USDCAD Price: Canadian Dollar Rallies on Upbeat Dec Jobs Data

The USDCAD currency pair was trading down over 100 pips from its daily highs after reversing course during the American session following the release of upbeat Canadian jobs data, which surpassed the US nonfarm payroll data r

Simon Mugo
Spruce Biosciences (SPRB) Stock Soared 165.6% on a $15M Deal

Spruce Biosciences Inc (NASDAQ: SPRB) stock price soared 165.6% after entering a strategic partnership and exclusive licensing agreement with Kaken Pharmaceuticals to develop and commercialise tildacerfont. The drug treats co

Simon Mugo
CytomX Therapeutics (CTMX) Stock Rallied 81.6% – Here’s Why

The CytomX Therapeutics Inc (NASDAQ: CTMX) stock price rallied higher after releasing an update about its 2023 priorities and progress in its drug pipeline. The company also announced a $35 million licensing deal with Moderna

Simon Mugo
Bitcoin and Ethereum Poised into US Employment Report

The two largest cryptocurrencies, Bitcoin (BTC) and Ethereum (ETH), have been marking time in a consolidation range, but with a positive bias, since the holiday season and into early 2023. This leaves these markets poised int

Steve Miley
Why Avacta Shares Have Risen 11.8% in the First Week of 2023

The Avacta Group Plc (LON: AVCT) share price has risen 11.8% in the first week of 2023, driven by bullish investor sentiment towards the company. However, opinion about Avacta’s prospects is mixed among analysts and here’s wh

Simon Mugo
Wells Fargo Believes Bed Bath and Beyond Bankruptcy Filing May Be Imminent

Bed Bath & Beyond (NASDAQ: BBBY) issued a warning about its future on Thursday, stating that a bankruptcy filing is a possibility for the company.

Sam Boughedda
Tesla Share Price Does Not Reflect Long-Term Opportunities, Says Analyst

Tesla (NASDAQ: TSLA) shares fell a further 2.9% in Thursday's session as US indices declined following a positive start to the year. The

Sam Boughedda
Essentra Slides as Macro Headwinds Weigh

Essentra (LON: ESNT) shares fell in early Friday trading after the company said in a trading update for the 12 months ended December 31 that in the fourth quarter, slower global economic growth resulted in toughening market h

Sam Boughedda
Omega Diagnostics Shares Climb After First FoodPrint System Order

Omega Diagnostics (LON: ODX) opened higher Friday after it has now received the first purchase order for its FoodPrint system from a Clinical Laboratory Improvement Amendments (CLIA) certified laboratory in the US.

Sam Boughedda
Supply@Me (SYME) Shares Are Down 15.7% in a Week – Here’s Why

The Supply@Me Capital PLC (LON: SYME) share price has fallen 15.7% in the first week of January, driven by negative investor sentiment towards the company. The fintech company has not made any announcements this week.

Simon Mugo
Amigo Shares Fall As Investors Wait For Updates From the Lender

The Amigo Holdings PLC (LON: AMGO) share price fell 5.16% today as investors wait for updates from the guarantor lender. Many are waiting for Amigo to announce the much-awaited capital raise, despite the massive dilution of e

Simon Mugo